Psyence Biomedical Ltd.
PBM
$5.21
-$0.445-7.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 736.77% | 736.77% | 219.37% | -45.05% | -45.05% |
| Total Receivables | 229.26% | 229.26% | 565.43% | -- | -72.09% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -21.83% | -21.83% | 907.74% | -- | 317.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 21.62% | 21.62% | 0.00% | -- | 0.00% |
| Total Current Assets | 482.26% | 482.26% | 235.34% | -- | -29.15% |
|
|
|||||
| Total Current Assets | 482.26% | 482.26% | 235.34% | -- | -29.15% |
| Net Property, Plant & Equipment | 101.82% | 101.82% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 546.21% | 546.21% | 236.85% | -- | -28.81% |
|
|
|||||
| Total Accounts Payable | -53.43% | -53.43% | -11.91% | -- | -65.46% |
| Total Accrued Expenses | -59.92% | -59.92% | -- | -- | -22.51% |
| Short-term Debt | -- | -- | 76.64% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -70.89% | -70.89% | -- | -- | -- |
| Total Other Current Liabilities | -70.89% | -70.89% | -- | -- | -- |
| Total Current Liabilities | -95.09% | -95.09% | 112.50% | -- | 575.98% |
|
|
|||||
| Total Current Liabilities | -95.09% | -95.09% | 112.50% | -- | 575.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 76.64% | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -95.09% | -95.09% | 112.50% | -- | 575.98% |
|
|
|||||
| Common Stock & APIC | 33.88% | 33.88% | 5,490.56% | -- | 677.29% |
| Retained Earnings | 1.76% | 1.76% | -- | -- | -812.06% |
| Treasury Stock & Other | 292.38% | 292.38% | -- | -- | 118.32% |
| Total Common Equity | 161.26% | 161.26% | -27.80% | -5,375.30% | -5,375.30% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 161.26% | 161.26% | -27.80% | -5,375.30% | -5,375.30% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 161.26% | 161.26% | -27.80% | -5,375.30% | -5,375.30% |
|
|
|||||